BRIEF-Ablynx enters into cancer deal with UK's Spirogen
BRUSSELS Feb 25 (Reuters) - Ablynx NV : * Ablynx and Spirogen enter into a research collaboration to evaluate the
potential of novel toxin-nanobody drug conjugates in cancer
- White House reverses, says Obama met uncle and lived with him during law school
- South Africa mourns Mandela, will bury him on December 15 |
- RPT-UPDATE 1-Ford leans on global Mustang to burnish overseas image
- Flights delayed as air pollution hits record in Shanghai
- U.S. television, Twitter, alive with new version of 'Sound of Music'